Heterogeneity in β-Adrenergic Receptor Kinase Expression in the Lung Accounts for Cell-specific Desensitization of the β2-Adrenergic Receptor*

The principal mechanism of homologous desensitization of the β-adrenergic receptor (β2AR) is phosphorylation of the receptor by the βAR kinase (βARK) or other closely related G protein-coupled receptor kinases (GRKs). However, within a single organ such as the lung where many cell types express the receptor, the presence or extent of β2AR desensitization in different cells has been noted to be highly variable. We hypothesized that such variability in desensitization is due to significant cell-type differences in βARK expression and/or function. To approach this, in situ hybridization was carried out in the lung and indeed revealed heterogeneity in βARK gene expression. Quantitative studies using ribonuclease protection assays with cell lines revealed that the level of βARK mRNA in airway smooth muscle cells was ∼20% of that in bronchial epithelial cells and ∼11% of that in mast cells (6.65 ± 0.96 versus 32.6 ± 4.0 and 60.7 ± 1.5 relative units, respectively, p < 0.001). βARK2 gene expression was not detected in any of these cells. At the protein level, βARK expression in airway smooth muscle cells was nearly undetectable, being ∼10-fold less than that expressed on mast cells. The activities of the GRKs in cell extracts were assessed in vitro by quantitating their ability to phosphorylate rhodopsin in the presence of light. Consistent with the gene and protein expression results, a marked discrepancy in activities was observed between extracts derived from mast cells (90.7 ± 0.5 relative units) as compared to airway smooth muscle cells (9.28 ± 0.6 relative units, p < 0.001). In contrast, the activities of protein kinase A (the other kinase that phosphorylates β2AR) in these extracts were not different. We predicted, then, that airway smooth muscle β2AR would undergo minimal short-term (5 min) agonist-promoted desensitization as compared to the β2AR expressed on mast cells. Mast cell cAMP reached maximal levels after 90 s and did not further increase over time, indicative of receptor desensitization in this cell. In contrast, cAMP levels of airway smooth muscle cells did not plateau, increasing at a rate of 103 ± 9% per min, consistent with little desensitization over the study period. We conclude that there is significant cell-type variation in expression of βARK and that such variation is directly related to the extent of short-term agonist-promoted desensitization of the β2AR.

[1]  S. Liggett,et al.  G Protein-coupled Receptor Kinase Specificity for Phosphorylation and Desensitization of α2-Adrenergic Receptor Subtypes* , 1996, The Journal of Biological Chemistry.

[2]  R. Lefkowitz,et al.  Identification of the G Protein-coupled Receptor Kinase Phosphorylation Sites in the Human β2-Adrenergic Receptor* , 1996, The Journal of Biological Chemistry.

[3]  P. Barnes,et al.  Beta-adrenergic receptors and their regulation. , 1995, American journal of respiratory and critical care medicine.

[4]  D. McGraw,et al.  Regulation of the beta 2-adrenergic receptor and its mRNA in the rat lung by dexamethasone. , 1995, Experimental lung research.

[5]  I. Hall,et al.  Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. , 1995, American journal of respiratory cell and molecular biology.

[6]  R. Lefkowitz,et al.  Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. , 1995, Science.

[7]  M. Lohse,et al.  Sequestration and recycling of beta 2-adrenergic receptors permit receptor resensitization. , 1995, Molecular pharmacology.

[8]  S. Liggett,et al.  Four Consecutive Serines in the Third Intracellular Loop Are the Sites for β-Adrenergic Receptor Kinase-mediated Phosphorylation and Desensitization of the α2A-Adrenergic Receptor (*) , 1995, The Journal of Biological Chemistry.

[9]  James Inglese,et al.  Protein kinases that phosphorylate activated G protein‐coupled receptors , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  E. Nestler,et al.  Chronic Morphine Administration Increases β‐Adrenergic Receptor Kinase (βARK) Levels in the Rat Locus Coeruleus , 1994 .

[11]  S. Green,et al.  A proline-rich region of the third intracellular loop imparts phenotypic beta 1-versus beta 2-adrenergic receptor coupling and sequestration. , 1994, The Journal of biological chemistry.

[12]  S. Kelsen,et al.  Regulation of beta-agonist- and prostaglandin E2-mediated adenylyl cyclase activity in human airway epithelial cells. , 1994, American journal of respiratory cell and molecular biology.

[13]  D. Eaton,et al.  Ca(2+)-permeable channel associated with platelet-derived growth factor receptor in mesangial cells. , 1994, The American journal of physiology.

[14]  J. Benovic,et al.  Structure of the human gene encoding the beta-adrenergic receptor kinase. , 1994, The Journal of biological chemistry.

[15]  M. Chabre Regulation of cellular signal transduction pathways by desensitization and amplification , 1994 .

[16]  J. Benovic,et al.  A beta-adrenergic receptor kinase dominant negative mutant attenuates desensitization of the beta 2-adrenergic receptor. , 1994, The Journal of biological chemistry.

[17]  G. Nilsson,et al.  Phenotypic Characterization of the Human Mast‐Cell Line HMC‐1 , 1994, Scandinavian journal of immunology.

[18]  R. Lefkowitz,et al.  Differential desensitization and phosphorylation of three cloned and transfected alpha 2-adrenergic receptor subtypes. , 1994, The Journal of biological chemistry.

[19]  M. Böhm,et al.  Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. , 1994, Circulation research.

[20]  J. Benovic,et al.  Molecular cloning and expression of GRK6. A new member of the G protein-coupled receptor kinase family. , 1993, The Journal of biological chemistry.

[21]  R. Lefkowitz G protein—coupled receptor kinases , 1993, Cell.

[22]  J. Benovic,et al.  Cloning and expression of GRK5: a member of the G protein-coupled receptor kinase family. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  S. Liggett,et al.  Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Whitsett,et al.  Transcriptional elements from the human SP-C gene direct expression in the primordial respiratory epithelium of transgenic mice. , 1993, Developmental biology.

[25]  M. Caron,et al.  Overexpression of beta-arrestin and beta-adrenergic receptor kinase augment desensitization of beta 2-adrenergic receptors. , 1993, The Journal of biological chemistry.

[26]  R. Lefkowitz,et al.  Beta-adrenergic receptor sequestration. A potential mechanism of receptor resensitization. , 1993, The Journal of biological chemistry.

[27]  S. Liggett,et al.  Subtype-selective desensitization of alpha 2-adrenergic receptors. Different mechanisms control short and long term agonist-promoted desensitization of alpha 2C10, alpha 2C4, and alpha 2C2. , 1992, The Journal of biological chemistry.

[28]  D. Church,et al.  A novel G protein-coupled receptor kinase gene cloned from 4p16.3. , 1992, Human molecular genetics.

[29]  P. Barnes,et al.  Tolerance to the Nonbronchodilator Effects of Inhaled β2-Agonists in Asthma , 1992 .

[30]  T. Dawson,et al.  The G-protein-coupled receptor kinases beta ARK1 and beta ARK2 are widely distributed at synapses in rat brain , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  M. Caron,et al.  The receptor kinase family: primary structure of rhodopsin kinase reveals similarities to the beta-adrenergic receptor kinase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Caron,et al.  Cloning, expression, and chromosomal localization of beta-adrenergic receptor kinase 2. A new member of the receptor kinase family. , 1991, The Journal of biological chemistry.

[33]  J. Benovic Purification and characterization of beta-adrenergic receptor kinase. , 1987, Methods in enzymology.

[34]  R. Crystal,et al.  The Lung: Scientific Foundations , 1991 .

[35]  J. Thorner,et al.  Model systems for the study of seven-transmembrane-segment receptors. , 1991, Annual review of biochemistry.

[36]  M. Caron,et al.  Multiple pathways of rapid beta 2-adrenergic receptor desensitization. Delineation with specific inhibitors. , 1990, The Journal of biological chemistry.

[37]  T. Soderling,et al.  Specificities of autoinhibitory domain peptides for four protein kinases. Implications for intact cell studies of protein kinase function. , 1990, The Journal of biological chemistry.

[38]  M. Caron,et al.  Beta-adrenergic receptor kinase: primary structure delineates a multigene family. , 1989, Science.

[39]  M. Caron,et al.  Altered patterns of agonist-stimulated cAMP accumulation in cells expressing mutant beta 2-adrenergic receptors lacking phosphorylation sites. , 1989, Molecular pharmacology.

[40]  M. Caron,et al.  Phosphorylation sites on two domains of the beta 2-adrenergic receptor are involved in distinct pathways of receptor desensitization. , 1989, The Journal of biological chemistry.

[41]  H. Cheng,et al.  Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor protein. , 1989, The Journal of biological chemistry.

[42]  M. Caron,et al.  Inhibition of beta-adrenergic receptor kinase prevents rapid homologous desensitization of beta 2-adrenergic receptors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Caron,et al.  Inhibition of the beta-adrenergic receptor kinase by polyanions. , 1989, The Journal of biological chemistry.

[44]  C. Harris,et al.  Human bronchial epithelial cells with integrated SV40 virus T antigen genes retain the ability to undergo squamous differentiation. , 1988, Differentiation; research in biological diversity.

[45]  G. Dewald,et al.  Establishment of an immature mast cell line from a patient with mast cell leukemia. , 1988, Leukemia research.

[46]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[47]  L. Schwartz,et al.  Two types of human mast cells that have distinct neutral protease compositions. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[49]  E. Krebs,et al.  Studies on the kinetic mechanism of the catalytic subunit of the cAMP-dependent protein kinase. , 1983, The Journal of biological chemistry.

[50]  U Wilden,et al.  Light-dependent phosphorylation of rhodopsin: number of phosphorylation sites. , 1982, Biochemistry.